CompletedEarly Phase 1

Decreased Neuraxial Morphine After Cesarean Delivery

United States87 participantsStarted 2020-09-09

Plain-language summary

The purpose of this study is to compare 50mcg to 150mcg morphine in epidural for the goal of decreasing side effects of medication with lower dose in patients who receive a QL block

Who can participate

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All women presenting for scheduled cesarean delivery who desire a QL block Exclusion Criteria: * Women with pregnancies complicated by preeclampsia * Women with pregnancies complicated by insulin-treated diabetes * Women with pregnancies complicated by placental abnormalities * Women with pregnancies complicated by a history of opioid use disorder

What they're measuring

Outcome of side effects of intervention: pruritus

Timeframe: One assessment during hospital stay - up to postoperative day 2 (2 days following cesarean delivery)

Outcome of side effects of intervention: nausea

Timeframe: One assessment during hospital stay - up to postoperative day 2

Outcome of side effects of intervention: urinary retention

Timeframe: One assessment during hospital stay - up to postoperative day 2 (2 days following cesarean delivery)

Trial details

NCT IDNCT04279054

SponsorUniversity of Alabama at Birmingham

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-07-05

View on ClinicalTrials.gov More Anesthesia trials